The cholera-causing bacterium, Vibrio cholerae, is commonly found in aquatic environments, such as oceans, ponds, and rivers. There, the bacterium has evolved formidable skills to ensure its survival, growth, and occasional transmission to humans, especially in endemic areas of the globe.
One of the ways the pathogen defends itself against predatory aquatic amoebas involves "hitchhiking" them and hiding inside the amoeba. Once there, the bacterium resists digestion and establishes a replication niche within the host's osmoregulatory organelle. This organelle is essential for the amoeba to balance its internal water pressure with the pressure exerted by the environment.
In a new study, the group of Melanie Blokesch at EPFL in collaboration with the BioEM facility headed by Graham Knott has deciphered the molecular mechanisms that V. cholerae uses to colonize aquatic amoebas. The researchers demonstrated that the pathogen uses specific features that allow it to maintain its intra-amoebal replication niche and to ultimately escape from the succumbed host. Several of these features, including extracellular enzymes and motility, are considered minor virulence factors as they also play a role in human disease.
The study suggests that the aquatic milieu provides a training ground for V. cholerae and that adaptation towards amoebal predators might have contributed to V. cholerae's emergence as a major human pathogen.
"We are quite excited about these new data, as they support the hypothesis that predation pressure can select for specific features that might have dual roles - in the environment and within infected humans," says Blokesch. She also highlights that continuous funding by the ERC (StG & CoG) has been crucial for this project, "as studying the environmental lifestyle of the pathogen is a bit outside the mainstream research on pathogenesis."
Reference: Van der Henst C, et al. Molecular insights into Vibrio cholerae's intra-amoebal host-pathogen interactions. Nature Communications 27 August 2018. DOI: 10.1038/s41467-018-05976-x
Source: EPFL
Innovation and Infection Control: Highlights From W&H at Chicago Dental Midwinter Society Meeting
February 19th 2025Doris Schneider, senior marketing manager for North America for W&H North America, shares insights into the 160th Chicago Dental Society Midwinter Meeting, showcasing the Lexa Mini rapid sterilizer and Sanaa Power handpiece, designed for efficient sterilization and effortless dental procedures.
Why AL-CIP Certification Is a Game-Changer; Apply by February 28, 2025
February 17th 2025AL-CIP certification validates leadership in infection prevention, unlocking career growth and credibility. Hear from certified professionals on its impact and why you should apply today before applications close on February 28, 2025!
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.
Undermining Public Health: Nearly 1300 Cut From CDC With More to Come
February 14th 2025The Trump administration’s decision to terminate nearly 1,300 CDC employees weakens America’s public health defenses, jeopardizes critical research, and endangers the nation’s preparedness for future health crises.